BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 9765616)

  • 1. Development of high-grade renal cell carcinomas in rats independently of somatic mutations in the Tsc2 and VHL tumor suppressor genes.
    Toyokuni S; Okada K; Kondo S; Nishioka H; Tanaka T; Nishiyama Y; Hino O; Hiai H
    Jpn J Cancer Res; 1998 Aug; 89(8):814-20. PubMed ID: 9765616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic mutation of the tuberous sclerosis (Tsc2) tumor suppressor gene in chemically induced rat renal carcinoma cell.
    Urakami S; Tokuzen R; Tsuda H; Igawa M; Hino O
    J Urol; 1997 Jul; 158(1):275-8. PubMed ID: 9186374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low incidence of point mutations in H-, K- and N-ras oncogenes and p53 tumor suppressor gene in renal cell carcinoma and peritoneal mesothelioma of Wistar rats induced by ferric nitrilotriacetate.
    Nishiyama Y; Suwa H; Okamoto K; Fukumoto M; Hiai H; Toyokuni S
    Jpn J Cancer Res; 1995 Dec; 86(12):1150-8. PubMed ID: 8636003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High incidence of allelic loss on chromosome 5 and inactivation of p15INK4B and p16INK4A tumor suppressor genes in oxystress-induced renal cell carcinoma of rats.
    Tanaka T; Iwasa Y; Kondo S; Hiai H; Toyokuni S
    Oncogene; 1999 Jun; 18(25):3793-7. PubMed ID: 10391689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biallelic mutations of the Tsc2 gene in chemically induced rat renal cell carcinoma.
    Satake N; Urakami S; Hirayama Y; Izumi K; Hino O
    Int J Cancer; 1998 Sep; 77(6):895-900. PubMed ID: 9714060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of ras mutations and low incidence of p53 mutations in renal cell carcinomas induced by ferric nitrilotriacetate.
    Akiyama T; Hamazaki S; Okada S
    Jpn J Cancer Res; 1995 Dec; 86(12):1143-9. PubMed ID: 8636002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of integrin-associated protein (CD47) in rat kidney treated with a renal carcinogen, ferric nitrilotriacetate.
    Nishiyama Y; Tanaka T; Naitoh H; Mori C; Fukumoto M; Hiai H; Toyokuni S
    Jpn J Cancer Res; 1997 Feb; 88(2):120-8. PubMed ID: 9119739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal cell carcinoma development in the rat independent of alterations at the VHL gene locus.
    Walker C; Ahn YT; Everitt J; Yuan X
    Mol Carcinog; 1996 Feb; 15(2):154-61. PubMed ID: 8599582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma.
    Brauch H; Weirich G; Hornauer MA; Störkel S; Wöhl T; Brüning T
    J Natl Cancer Inst; 1999 May; 91(10):854-61. PubMed ID: 10340905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning of the rat homologue of the von Hippel-Lindau tumor suppressor gene and its non-somatic mutation in rat renal cell carcinomas.
    Kikuchi Y; Kobayashi E; Nishizawa M; Hamazaki S; Okada S; Hino O
    Jpn J Cancer Res; 1995 Oct; 86(10):905-9. PubMed ID: 7493907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma.
    Whaley JM; Naglich J; Gelbert L; Hsia YE; Lamiell JM; Green JS; Collins D; Neumann HP; Laidlaw J; Li FP
    Am J Hum Genet; 1994 Dec; 55(6):1092-102. PubMed ID: 7977367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Over-expression of glutathione S-transferase Yp isozyme and concomitant down-regulation of Ya isozyme in renal cell carcinoma of rats induced by ferric nitrilotriacetate.
    Tanaka T; Nishiyama Y; Okada K; Satoh K; Fukuda A; Uchida K; Osawa T; Hiai H; Toyokuni S
    Carcinogenesis; 1998 May; 19(5):897-903. PubMed ID: 9635880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of the von hippel lindau gene in clear cell renal carcinomas from tuberous sclerosis complex patients.
    Duffy K; Al-Saleem T; Karbowniczek M; Ewalt D; Prowse AH; Henske EP
    Mod Pathol; 2002 Mar; 15(3):205-10. PubMed ID: 11904337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions.
    Gallou C; Chauveau D; Richard S; Joly D; Giraud S; Olschwang S; Martin N; Saquet C; Chrétien Y; Méjean A; Correas JM; Benoît G; Colombeau P; Grünfeld JP; Junien C; Béroud C
    Hum Mutat; 2004 Sep; 24(3):215-24. PubMed ID: 15300849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of von Hippel-Lindau disease gene mutations in paraffin-embedded sporadic renal cell carcinoma specimens.
    Zhuang Z; Gnarra JR; Dudley CF; Zbar B; Linehan WM; Lubensky IA
    Mod Pathol; 1996 Aug; 9(8):838-42. PubMed ID: 8871925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
    Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
    Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic VHL alteration and its impact on prognosis in patients with clear cell renal cell carcinoma.
    Kim JH; Jung CW; Cho YH; Lee J; Lee SH; Kim HY; Park J; Park JO; Kim K; Kim WS; Park YS; Im YH; Kang WK; Park K
    Oncol Rep; 2005 May; 13(5):859-64. PubMed ID: 15809750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic von Hippel-Lindau disease gene mutation in clear-cell renal carcinomas associated with end-stage renal disease/acquired cystic disease of the kidney.
    Yoshida M; Yao M; Ishikawa I; Kishida T; Nagashima Y; Kondo K; Nakaigawa N; Hosaka M
    Genes Chromosomes Cancer; 2002 Dec; 35(4):359-64. PubMed ID: 12378530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.
    Lubensky IA; Gnarra JR; Bertheau P; Walther MM; Linehan WM; Zhuang Z
    Am J Pathol; 1996 Dec; 149(6):2089-94. PubMed ID: 8952541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stage-specific roles of fibulin-5 during oxidative stress-induced renal carcinogenesis in rats.
    Ohara H; Akatsuka S; Nagai H; Liu YT; Jiang L; Okazaki Y; Yamashita Y; Nakamura T; Toyokuni S
    Free Radic Res; 2011 Feb; 45(2):211-20. PubMed ID: 20942562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.